mhurhangee/ep-ind-claims huggingface dataset:
A crimp terminal and a covered electric wire with terminal of which an end portion is connected to the crimp terminal in which a barrel section to be wound around and crimped to an end portion (W1a) of a covered electric wire having an aluminum core wire at which the aluminum core wire is exposed, and a terminal section to be connected to a connection object are arranged in a predetermined axial direction, wherein the barrel section includes: a bottom plate section extending in the axial direction, on which the end portion of the covered electric wire is to be placed; and an inner barrel piece and an outer barrel piece extending from the bottom plate section on both sides in a crossing direction intersecting the axial direction in plan view with respect to the bottom plate section, wherein a sealing member formed of an adhesive gel is affixed across a first region (11a-1) that longitudinally traverses the outer barrel piece in the axial direction, a second region (11a-2) which traverses the inner surface in the crossing direction at a position close to the terminal section, and a third region (11a-3) that traverses the inner surface in the crossing direction so as to intersect a covered portion of the end portion, wherein a plurality of concave sections is dispersedly provided on an inner surface of the barrel section, a groove section is provided on at least the third region so as to overlap the sealing member, and a ridge portion is provided extending in the crossing direction at a position which does not overlap with the sealing member in plan view and is close to the third region (11a-3), wherein the barrel section is crimped to the end portion by crimping so that the exposed portion of the aluminum core wire at the end portion is in contact with the ridge portion, and the sealing member seals between the inner barrel piece and the outer barrel piece, an opening of the barrel section which is to be cylindrical on a side of the terminal section, and between the covered portion and the barrel section.
Unit for a flow-ducting system, with a pump-drive module (11, 11'), the pump-drive module (11, 11') comprising a drive module, and a pump module having an impeller that can be driven by said drive module, the unit comprising a casing having at least one inlet side and at least one outlet side (5, 6) and a moveable shut-off device (10, 10') arranged between them, a flow path between the inlet side and the outlet side (5, 6) being formed in at least one position of the shut-off device (10, 10'), and the pump module being arranged in the flow path between the inlet side and the outlet side (5, 6), the unit, in at least one further position of the shut-off device (10, 10'), being capable of shutting off the flow path in such a way that the shut-off device (10, 10') and the unit casing form an area, which is separated from the flow path and which is sealed off from the inlet side and the outlet side, the pump-drive module (11, 11') being arranged inside this area, and the pump-drive module (11, 11') being arranged in the shut-off device (10, 10'), characterized in that the pump-drive module (11, 11') is removable from the unit or capable of insertion into the unit when the flow path is shut off.
A first network repository function, NRF, for decentralized network entity authentication in a mobile network, wherein the first NRF comprises a processor being configured to: receive a request from a first network function, NF,, wherein the request comprises an identification, ID, of a second NRF; and send a response to the first NF, wherein the response comprises a verification tool of the second NRF. receive a request from a first network function, NF,, wherein the request comprises an identification, ID, of a second NRF; and send a response to the first NF, wherein the response comprises a verification tool of the second NRF.
Respiratory protective mask for covering the mouth and nose of a person, comprising a multi-layer mask blank with a filter layer of a filter medium, wherein the one filter layer is arranged between an outer covering layer, which forms an outer side facing away from the face of the person when the respiratory protective mask is worn, and an inner cover layer, which forms an inner side of the respiratory protective mask facing the face of the person when the respiratory protective mask is worn, the filter layer being coated with a salt layer at least in sections on its surfaces, and further comprising fastening means for fastening the respiratory protective mask to the head of the person, characterized in that two or more filter layers (4, 5, 6) of a filter medium are arranged between the outer and the inner cover layer, each of the two or more filter layers (4, 5, 6) being coated at least in sections with a salt layer, the salt layer being formed from at least one inorganic salt which contains a sodium salt, and the filter layers (4, 5, 6) being connected at least in sections to one another and to the outer and inner cover layers.
A method of determining the presence or absence of, or response to therapy against, an ovarian cancer in a woman, said method comprising the steps: • providing a biological sample from said woman, said sample comprising cell-free DNA of said woman; and • determining, in at least one molecule of said cell-free DNA, the methylation status at one or more CpGs located within one or more of the nucleotide sequences independently selected from the group consisting of: SEQ ID NOs: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30 and 31, or a nucleotide sequence present within about 2,000bp (such as within about 200bp) 5' or 3' thereof, or an allelic variant and/or complementary sequence of said nucleotide sequence(s), wherein at least one of said nucleotide sequences is SEQ ID NO: 1 or an allelic variant and/or complementary sequence of said nucleotide sequence, and the methylation status at two or more CpGs located within said nucleotide sequence of SEQ ID NO:1 is determined; wherein, the presence in at least one of said cell-free DNA molecules of two or more methylated CpGs located in the nucleotide sequence of SEQ ID NO: 1 and optionally one or more: (i) methylated CpGs associated with (such as located within) one or more of said nucleotide sequences independently selected from: SEQ ID NOs: 2, 3, 4, 10, 12, 14, 15, 18, 19, 20, 21, 23, 24, 25, 26, 27, 28, 29 and 30; and/or (ii) un-methylated CpGs associated with (such as located within) one or more of said nucleotide sequences independently selected from: SEQ ID NOs: 5, 6, 7, 8, 9, 11, 13, 16, 17, 22 and 31, indicates the presence of, or a reduced response to therapy against, an ovarian cancer in said woman; preferably wherein said biological sample is liquid biological sample selected from the group consisting of: a blood sample, a plasma sample and a serum sample. • providing a biological sample from said woman, said sample comprising cell-free DNA of said woman; and • determining, in at least one molecule of said cell-free DNA, the methylation status at one or more CpGs located within one or more of the nucleotide sequences independently selected from the group consisting of: SEQ ID NOs: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30 and 31, or a nucleotide sequence present within about 2,000bp (such as within about 200bp) 5' or 3' thereof, or an allelic variant and/or complementary sequence of said nucleotide sequence(s), wherein at least one of said nucleotide sequences is SEQ ID NO: 1 or an allelic variant and/or complementary sequence of said nucleotide sequence, and the methylation status at two or more CpGs located within said nucleotide sequence of SEQ ID NO:1 is determined;
A feminine hygiene pad comprising a liquid-permeable topsheet, a liquid-impermeable backsheet, and an absorbent layer disposed between the topsheet and the backsheet, wherein the topsheet comprises a hydrophilic fibrous nonwoven web material comprising spun bicomponent fibers and a wearer-facing layer of spun monocomponent fibers, and having a capillary work potential in drainage or desorption mode CWPD; wherein the absorbent layer comprises an open-celled foam formed through polymerization of a HIPE; wherein the absorbent layer has a capillary work potential in absorption mode CWPA greater than the CWPD, and has a caliper (prior to wetting) of 1 mm to 5 mm, or more preferably 1.5 mm to 3.5 mm, or even more preferably 2.0 mm to 3.0 mm; wherein the topsheet and the absorbent layer are disposed in direct face-to-face relationship with each other, and attached to each other within a bonding region of at least 15 cm 2, more preferably at least 30 cm 2, and even more preferably at least half of a surface area of a wearer-facing surface of the absorbent layer wherein within the bonding region, each first identifiable point of attachment between the topsheet and the absorbent layer has a neighboring second identifiable point of attachment between the topsheet and the absorbent layer within a 6 mm radius of the first identifiable point of attachment; and wherein the absorbent layer comprises at least two absorbent sublayers comprising a relatively larger-celled, wearer-facing sublayer disposed in contact with a relatively smaller-celled, outward-facing sublayer. wherein the topsheet comprises a hydrophilic fibrous nonwoven web material comprising spun bicomponent fibers and a wearer-facing layer of spun monocomponent fibers, and having a capillary work potential in drainage or desorption mode CWPD; wherein the absorbent layer comprises an open-celled foam formed through polymerization of a HIPE; wherein the absorbent layer has a capillary work potential in absorption mode CWPA greater than the CWPD, and has a caliper (prior to wetting) of 1 mm to 5 mm, or more preferably 1.5 mm to 3.5 mm, or even more preferably 2.0 mm to 3.0 mm; wherein the topsheet and the absorbent layer are disposed in direct face-to-face relationship with each other, and attached to each other within a bonding region of at least 15 cm 2, more preferably at least 30 cm 2, and even more preferably at least half of a surface area of a wearer-facing surface of the absorbent layer wherein within the bonding region, each first identifiable point of attachment between the topsheet and the absorbent layer has a neighboring second identifiable point of attachment between the topsheet and the absorbent layer within a 6 mm radius of the first identifiable point of attachment; and wherein the absorbent layer comprises at least two absorbent sublayers comprising a relatively larger-celled, wearer-facing sublayer disposed in contact with a relatively smaller-celled, outward-facing sublayer.
A quantitative detection kit for determining ITGA4 gene methylation in at least one sample selected from a group consisting of feces, tissue or cells comprising: an ITGA4 gene capturing reagent comprising: a magnetic bead probe complex comprising: a first probe of nucleotide sequence as shown in SEQ ID NO: 1; and an ITGA4 gene methylation quantitative detection reagent comprising: a primer of nucleotide sequences as shown in SEQ ID NO: 4-5, and a second probe of nucleotide sequence as shown in SEQ ID NO: 6. an ITGA4 gene capturing reagent comprising: a magnetic bead probe complex comprising: a first probe of nucleotide sequence as shown in SEQ ID NO: 1; and an ITGA4 gene methylation quantitative detection reagent comprising: a primer of nucleotide sequences as shown in SEQ ID NO: 4-5, and a second probe of nucleotide sequence as shown in SEQ ID NO: 6. a primer of nucleotide sequences as shown in SEQ ID NO: 4-5, and a second probe of nucleotide sequence as shown in SEQ ID NO: 6.
A battery system (10,10a) including a combination of first and second batteries (100, 200), wherein the first and second batteries (100, 200) have a discharge characteristic that includes a stable region and an unstable region defined by a voltage change rate with respect to a discharged capacity, the stable region has a small voltage change rate with respect to the discharge capacity compared with the unstable region, characterised in that, the first battery has a discharge characteristic that includes the unstable region in a last phase side of discharge toward a state of complete discharge in a voltage range including a voltage in the stable region of the second battery, the second battery has a discharge characteristic that includes: a stable region in a voltage range lower than a voltage of the stable region of the first battery; and an unstable region in an initial phase side of discharge starting from a fully-charged state in a voltage range including a voltage in the stable region of the first battery, the first battery and the second battery are connected to each other in parallel so that a state of discharge of an entire battery including the first battery and the second battery transitions from an end portion of the stable region of the first battery to a start portion of the stable region of the second battery in a discharge process of the entire battery, and the voltage of the end portion in the stable region of the first battery substantially matches with the voltage of the start portion of the stable region of the second battery.
Device for generating aerosols, comprising: a cartridge nozzle with a reservoir container for accommodating an agent and a nozzle to bring out the agent into the environment, a fluid pressure source for accommodating a fluid being under overpressure, wherein the cartridge nozzle can be supplied with a mass flow of fluid by the fluid pressure source, wherein the cartridge nozzle is adapted in a way that, during the cartridge nozzle is supplied, the mass flow of fluid from the fluid pressure source flows through the cartridge nozzle and, thereafter, escapes into the environment, wherein the cartridge nozzle is adapted in a way that an agent can be added to the mass flow of fluid by the cartridge nozzle, wherein the cartridge nozzle can be positioned in an accommodation at the device, characterized in that the accommodation is supported rotatable around an axis of the device, wherein the at least one cartridge nozzle can be connected and disconnected with the fluid pressure source by rotating the accommodation. a cartridge nozzle with a reservoir container for accommodating an agent and a nozzle to bring out the agent into the environment, a fluid pressure source for accommodating a fluid being under overpressure, wherein the cartridge nozzle can be supplied with a mass flow of fluid by the fluid pressure source, wherein the cartridge nozzle is adapted in a way that, during the cartridge nozzle is supplied, the mass flow of fluid from the fluid pressure source flows through the cartridge nozzle and, thereafter, escapes into the environment, wherein the cartridge nozzle is adapted in a way that an agent can be added to the mass flow of fluid by the cartridge nozzle, wherein the cartridge nozzle can be positioned in an accommodation at the device, characterized in that the accommodation is supported rotatable around an axis of the device, wherein the at least one cartridge nozzle can be connected and disconnected with the fluid pressure source by rotating the accommodation.
A roll-up traction mat for a vehicle having at least one wheel, said traction mat having a bottom face and a top face constituting a running track, and comprising a main track portion, as well as a track starter tab that is fastened to a first end of the main track portion by a hinge-forming connection portion arranged to lower the track starter tab relative to the main track portion, by means of which the track starter tab can be positioned at the bottom of a rut in which said wheel of the vehicle is stuck, the track starter tab comprising a plurality of stiffener elements extending transversely, characterized in that the track starter tab comprises a top face provided with studs, the main track portion and the track starter tab being constituted by at least one textile layer covered in a polymer layer.
An anti-fog coating, comprising: a cationically polymerizable compound including at least one epoxy group; a radically polymerizable compound including at least one acrylate group; a non-ionic surfactant; and an ionic surfactant. a cationically polymerizable compound including at least one epoxy group; a radically polymerizable compound including at least one acrylate group; a non-ionic surfactant; and an ionic surfactant.
Positioning device arranged to determine a position using an absolute positioning system and a relative positioning system, and further arranged to work in a first mode, in which the position is determined using at least the absolute positioning system, and in a second mode, in which the position is determined using at least the relative positioning system in combination with a starting position determined by the absolute positioning system, and being further arranged to switch from the first mode to the second mode, characterised in that: the positioning device is further arranged to keep a history file, the history file comprising: a plurality of positions previously determined by the absolute positioning system and an associated accuracy for each of the plurality of determined positions; and measurements determined by the relative positioning system, and wherein, when a switch is made from the first mode to the second mode, the positioning device is further arranged to check the history file and to select one of the plurality of positions determined by the absolute positioning system as the starting position for the relative positioning system based on the accuracy information stored in the history file. the positioning device is further arranged to keep a history file, the history file comprising: a plurality of positions previously determined by the absolute positioning system and an associated accuracy for each of the plurality of determined positions; and measurements determined by the relative positioning system, and wherein, when a switch is made from the first mode to the second mode, the positioning device is further arranged to check the history file and to select one of the plurality of positions determined by the absolute positioning system as the starting position for the relative positioning system based on the accuracy information stored in the history file.
An apparatus configured to be employed within an evolved NodeB, eNB, (100, 200) comprising: a radio frequency, RF, circuitry component configured to process or generate communication signals on an unlicensed spectrum; and a baseband component, coupled to the RF circuitry component, configured to generate a clear channel assessment of one or more secondary cell network devices by performing a listen before talk, LBT, protocol, to detect whether a channel of the one or more secondary cell network devices is busy or idle, and in response to the detecting the channel of the one or more second cell network devices is idle, generate a downlink transmission via the channel in the unlicensed spectrum based on the channel assessment after a random duration that is specified within a predetermined interval of the downlink transmission, wherein the apparatus is further configured to provide a modification of a cell-specific reference signal, CRS, sequence within a partial subframe, the modification of the CRS sequence signaling information regarding the presence and the duration of the partial subframe at the beginning of the downlink transmission or at the end of the downlink transmission. a radio frequency, RF, circuitry component configured to process or generate communication signals on an unlicensed spectrum; and a baseband component, coupled to the RF circuitry component, configured to generate a clear channel assessment of one or more secondary cell network devices by performing a listen before talk, LBT, protocol, to detect whether a channel of the one or more secondary cell network devices is busy or idle, and in response to the detecting the channel of the one or more second cell network devices is idle, generate a downlink transmission via the channel in the unlicensed spectrum based on the channel assessment after a random duration that is specified within a predetermined interval of the downlink transmission, wherein the apparatus is further configured to provide a modification of a cell-specific reference signal, CRS, sequence within a partial subframe, the modification of the CRS sequence signaling information regarding the presence and the duration of the partial subframe at the beginning of the downlink transmission or at the end of the downlink transmission.
A method of reducing the amount of sulfur in a composition comprising sulfur, the method comprising the steps of: a. providing a composition comprising sulfur; wherein the composition comprising sulfur comprises petroleum, and b. contacting the composition comprising sulfur with an oxidation agent and an oxidation catalyst, wherein the oxidation catalyst has the formula M 1 1-x M 3 x M 2 O 3, wherein M 1 is a rare-earth element, wherein M 2 is a transition metal, wherein M 3 is Ca or Sr, and wherein x is from 0.01 to 0.80, wherein the oxidation catalyst is a nano-crystalline form, wherein the oxidation agent comprises H 2 O 2 NO 2, N 2 O 3, N 2 O 4, acetic acid, formic acid, sulfuric acid, nitric acid, O 2, air, or ozone, or a combination thereof, thereby reducing the amount of sulfur in the composition comprising sulfur. a. providing a composition comprising sulfur; wherein the composition comprising sulfur comprises petroleum, and b. contacting the composition comprising sulfur with an oxidation agent and an oxidation catalyst, wherein the oxidation catalyst has the formula M 1 1-x M 3 x M 2 O 3, wherein M 1 is a rare-earth element, wherein M 2 is a transition metal, wherein M 3 is Ca or Sr, and wherein x is from 0.01 to 0.80, wherein the oxidation catalyst is a nano-crystalline form, wherein the oxidation agent comprises H 2 O 2 NO 2, N 2 O 3, N 2 O 4, acetic acid, formic acid, sulfuric acid, nitric acid, O 2, air, or ozone, or a combination thereof,
A method for obtaining mesenchymal stem cell -derived cells of chondro-osteoblastic lineage from MSC, the method comprising: (a) culturing MSC recovered from a biological sample of a subject in a culture medium comprising fibroblast growth factor-2 (FGF-2), transforming growth factor beta (TGFβ) and heparin or a derivative or analogue thereof at a concentration of at least 0.01 IU/ml, thereby obtaining mesenchymal stem cell -derived cells; (b) passaging the MSC-derived cells for a first time and further culturing the MSC-derived cells in a medium as defined in (a); and (c) passaging the MSC-derived cells for a second time and further culturing the MSC-derived cells in a medium as defined in (a), thereby obtaining the MSC-derived cells of chondro-osteoblastic lineage, wherein the MSC-derived cells are cultured in step (b) for a period of x days, wherein day x is the last day on which at least 20% of the MSC-derived cells are proliferating. (a) culturing MSC recovered from a biological sample of a subject in a culture medium comprising fibroblast growth factor-2 (FGF-2), transforming growth factor beta (TGFβ) and heparin or a derivative or analogue thereof at a concentration of at least 0.01 IU/ml, thereby obtaining mesenchymal stem cell -derived cells; (b) passaging the MSC-derived cells for a first time and further culturing the MSC-derived cells in a medium as defined in (a); and (c) passaging the MSC-derived cells for a second time and further culturing the MSC-derived cells in a medium as defined in (a), thereby obtaining the MSC-derived cells of chondro-osteoblastic lineage,